Yu-Ju Chen Selected Research

Yu-Ju Chen Research Topics

Disease

39	Neoplasms (Cancer) 04/2024 - 09/2004
14	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2011
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 09/2008
9	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2006
8	Stomach Neoplasms (Stomach Cancer) 06/2017 - 09/2004
7	Inflammation (Inflammations) 08/2023 - 09/2008
5	Adenocarcinoma of Lung 04/2024 - 01/2011
4	Hypoxia (Hypoxemia) 08/2023 - 12/2016
4	Carcinogenesis 01/2022 - 01/2013
4	Hepatocellular Carcinoma (Hepatoma) 08/2021 - 01/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 07/2010
3	Atherosclerosis 01/2023 - 03/2020
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2022
3	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2016
3	Immune System Diseases (Immune Disorders) 01/2020 - 01/2014
2	Ischemia 11/2023 - 12/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2018
2	Stroke (Strokes) 12/2020 - 01/2019
2	Fibrosis (Cirrhosis) 01/2020 - 03/2013
2	Genomic Instability 01/2019 - 01/2016
2	Chondrosarcoma 11/2017 - 05/2015
2	Infections 01/2010 - 12/2004
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023
1	Nervous System Diseases (Neurological Disorders) 09/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Biliary Atresia 01/2023
1	Lymphocytosis 01/2023
1	Leukemia 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Thrombophilia 07/2022
1	Thrombosis (Thrombus) 07/2022

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2004
17	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2004
10	ProteomeIBA 01/2023 - 12/2004
9	Phosphotransferases (Kinase)IBA 11/2023 - 01/2011
6	Membrane Proteins (Integral Membrane Proteins)IBA 12/2015 - 10/2008
5	PhosphoproteinsIBA 01/2023 - 09/2008
4	Peptides (Polypeptides)IBA 01/2024 - 12/2015
4	GlycopeptidesIBA 12/2021 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2013
3	EnzymesIBA 08/2023 - 01/2013
3	CytokinesIBA 08/2023 - 10/2015
3	ChemokinesIBA 02/2023 - 01/2010
3	Apolipoproteins E (ApoE)IBA 01/2023 - 03/2020
3	Gefitinib (Iressa)FDA Link 01/2023 - 06/2015
3	PhosphopeptidesIBA 01/2021 - 11/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020 - 11/2014
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2017 - 09/2004
2	ErbB Receptors (EGF Receptor)IBA 01/2024 - 10/2008
2	AntibodiesIBA 10/2023 - 01/2013
2	Messenger RNA (mRNA)IBA 09/2023 - 03/2015
2	MicroRNAs (MicroRNA)IBA 08/2023 - 01/2019
2	ApolipoproteinsIBA 01/2023 - 03/2020
2	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2023 - 12/2021
2	ibrutinibIBA 01/2023 - 01/2022
2	VimentinIBA 01/2022 - 10/2006
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 03/2013
2	TransferasesIBA 01/2020 - 11/2015
2	Ligases (Synthetase)IBA 01/2020 - 12/2016
2	UbiquitinIBA 01/2020 - 12/2016
2	CalciumIBA 01/2019 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2012
2	AmphiregulinIBA 11/2017 - 05/2015
2	Integrin alpha6beta1IBA 11/2017 - 05/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017 - 05/2015
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 06/2015
2	imidazoleacetic acid (IMAC)IBA 01/2014 - 09/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2013 - 01/2012
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2004 - 09/2004
1	RoscovitineIBA 11/2023
1	Oxygen (Dioxygen)IBA 11/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2023
1	Chimeric Antigen ReceptorsIBA 10/2023
1	AntigensIBA 10/2023
1	Rituximab (Mabthera)FDA Link 10/2023
1	CollagenIBA 08/2023
1	Collagen Type II (Type II Collagen)IBA 08/2023
1	Chemokine CCL5IBA 02/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2023
1	cadherin 5IBA 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	G-Protein-Coupled Receptor Kinase 2IBA 01/2023
1	VinculinIBA 01/2023
1	CateninsIBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	duvelisibIBA 01/2023
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2023
1	Fibrinogen (Factor I)FDA Link 07/2022
1	AnticoagulantsIBA 07/2022
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	LigandsIBA 01/2022
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2022
1	SialoglycoproteinsIBA 12/2021
1	acetonitrileIBA 12/2021

Therapy/Procedure

12	Therapeutics 10/2023 - 10/2008
3	Drug Therapy (Chemotherapy) 03/2020 - 11/2014
2	Immunotherapy 01/2023 - 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2023